Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Hangzhou Tigermed Consulting Co Ltd

+ Add to Watchlist

300347:CH

43.290 CNY 0.250 0.58%

As of 00:50:21 ET on 02/27/2015.

Snapshot for Hangzhou Tigermed Consulting Co Ltd (300347)

Open: 43.300 Day's Range: 42.530 - 43.540 Volume: 1,466,337
Previous Close: 43.040 52wk Range: 26.550 - 46.980 1-Yr Rtn: -

Stock Chart for 300347

No chart data available.
  • 300347:CH 43.290
  • 1D
  • 1M
  • 1Y
43.040
Interactive 300347 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300347

Current P/E Ratio (ttm) 98.4091
Estimated P/E(12/2014) 75.9649
Relative P/E vs. SZ399006 1.3862
Earnings Per Share (CNY) (ttm) 0.4400
Est. EPS (CNY) (12/2014) 0.5700
Est. PEG Ratio -
Market Cap (M CNY) 9,310.33
Shares Outstanding (M) 215.02
30 Day Average Volume 2,654,468
Price/Book (mrq) 12.4317
Price/Sale (ttm) 27.6065
Dividend Indicated Gross Yield 0.46%
Cash Dividend (CNY) 0.2000
Dividend Ex-Date 04/22/2014
5 Year Dividend Growth -
Next Earnings Announcement 04/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300347

No data available

Company Profile & Key Executives for 300347

Hangzhou Tigermed Consulting Company Limited provides professional clinical research services for domestic and foreign pharmaceutical and health-related research and development. The Company's main services include clinical trial technology services, data management, and statistical analysis.

Ye XiaopingChairman/PresidentXu JialianVice President
Wen ChenVice PresidentZhuan YinVice President
More Company Profile & Key Executives for 300347

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil